Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (2)
  • 2022 (3)
  • 2021 (8)

Subject

  • Drug Trafficking (1418)
  • Synthetic drugs (411)
  • Guns/Weapons (339)
  • OCDETF/Task Force (212)
  • Fake Pills (203)
  • Guilty Plea (194)
  • Arrests/Convictions - Major (175)
  • Seizures (Drugs/Property) (159)
  • Major Law Enforcement Operation (71)
  • Money Laundering (49)
  • Gangs (39)
  • Task Forces/Task Force Officers (38)
  • Overdose (23)
  • HIDTA (20)
  • Press Conferences (14)
  • Prescription Drugs (12)
  • Fentanyl Awareness (11)
  • Asset Forfeiture (9)
  • Prevention/Education - DEA websites GSAD, JTT etc (9)
  • One Pill Can Kill (8)
  • Dark Web- Internet Trafficking (7)
  • Narcoterrorism (7)
  • Diversion Division (5)
  • Public and Media Affairs - also see Congressional Affairs (5)
  • Extraditions (4)
  • Pharmaceuticals/Pharmacists/Physicians (3)
  • Intelligence Division - Intelligence Products (1)
  • Take Back Day (1)
  • Outreach/Drug Prevention (13)

Drug Name

  • Fentanyl (53)
  • Opioids (17)
  • Synthetic Opioids (16)
  • Cocaine (3)
  • Marijuana (Cannabis) (3)
  • Amphetamines (2)
  • Benzodiazepines (2)
  • Oxycodone (2)
  • Methamphetamine (13)
  • Marijuana Concentrates (0)

Field Division

  • Washington, DC (5)
  • Headquarters (3)
  • Houston (1)
  • New England (1)
  • Omaha (1)
  • Phoenix (1)
  • San Diego (1)
Clear All Results
PRESS RELEASE

DEA Washington Division Calls on the Community to Have Important Conversations on Dangers of Drugs and Fake Pills in Back-To-School Routines

August 22, 2024
Washington, DC – As schools in the District of Columbia, Maryland, and Virginia open their doors to students and teachers this month, the Drug Enforcement Administration (DEA) Washington Division is urging the community to have important conversations about the consequences of drug experimentation and misuse as the new school year...
August 22, 2024
PRESS RELEASE

DEA Washington Division Saw a Surge of Over 250% in Fentanyl Pill Seizures in 2023

January 26, 2024
Washington, DC – The Drug Enforcement Administration’s (DEA) Washington Division, which covers the District of Columbia, Maryland, and Virginia (DMV) confiscated more than 639,000 fentanyl pills and 189 pounds of fentanyl powder in 2023. This amount represents more than a three-fold increase in the number of fake pills laced with...
January 26, 2024
PRESS RELEASE

DEA Holds Inaugural Family Summit on the Overdose Epidemic

June 15, 2022
WASHINGTON – On June 14 and 15, DEA Administrator Anne Milgram hosted the first-ever DEA Family Summit on the Overdose Epidemic for families from across the country who have experienced the profound loss of a child due to a drug overdose or poisoning. Deputy Attorney General Lisa O. Monaco delivered...
June 15, 2022
PRESS RELEASE

La DEA Inicia el Primer Año de la Operación Engage en Richmond, VA

May 06, 2022
Richmond, Virginia – Hoy, la División de Washington de la Administración para el Control de Drogas (DEA, por sus siglas en inglés) anunció el inicio de la Operación Engage en Richmond, Virginia. La cual es una iniciativa integral a nivel comunitario implementada para combatir y abordar los problemas asociados a...
May 06, 2022
PRESS RELEASE

DEA Launches First Year of Operation Engage in Richmond, VA

May 06, 2022
Richmond, Va., – Today, the Drug Enforcement Administration's (DEA) Washington Division announces the launch of Operation Engage in Richmond, Virginia. Operation Engage is comprehensive, community-level initiative, implemented to target and address the drug and related violence issues in cities with high levels of drug related problems. Operation Engage is new...
May 06, 2022
PRESS RELEASE

Administrator Anne Milgram Remarks on the Overdose Epidemic

November 17, 2021
Thank you and good morning. Thank you to ONDCP and to all the federal partners with whom we have been working on this important issue. This is a critical moment in our country. DEA’s mission is to keep American communities safe and healthy and we are in the midst of...
November 17, 2021
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

September 28, 2021
Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide surge in counterfeit...
September 28, 2021
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

September 27, 2021
PHOENIX - Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide surge...
September 27, 2021
PRESS RELEASE

DEA Washington Chief Issues Public Safety Alert: Dangerous Increase in Fake Rx Pills Containing Fentanyl

September 27, 2021
Washington, D.C. – Today, Jarod Forget, Special Agent in Charge of the DEA Washington Division issued a Public Safety Alert warning Maryland, Virginia, and Washington, D.C. residents of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl in our area. This DEA Public Safety Alert...
September 27, 2021
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

September 27, 2021
WASHINGTON, DC – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
September 27, 2021
Showing 1 - 10 of 13 results

Pagination

  • Current page 1
  • Page 2
  • Next page ›
  • Last page »

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español